Clinical Practice Guidelines: Cochlear Implants

Clinical Policy Bulletin: Cochlear Implants and Auditory Brainstem Implants

A. Member has bilateral severe to profound sensorineural hearing loss determined by a pure tone average of 70 dB or greater at 500 Hz, 1000 Hz, and 2000 Hz; and B. Member has limited benefit from appropriately fitted binaural hearing aids. Limited benefit from amplification is defined by test scores of 40 % correct or less in best-aided listening condition on open-set sentence cognition (e.g., ...

Clinical Management of Children with Cochlear Implants.

Clinical Practice Guidelines EASL Clinical Practice Guidelines: Wilson’s disease

This Clinical Practice Guideline (CPG) has been developed to assist physicians and other healthcare providers in the diagnosis and management of patients with Wilson’s disease. The goal is to describe a number of generally accepted approaches for diagnosis, prevention, and treatment of Wilson’s disease. Recommendations are based on a systematic literature review in the Medline (PubMed version),...

NHG Clinical Practice Guidelines NHG Clinical Practice Guidelines

Speech Perception in Children with Cochlear Implants

Cochlear implants provide access to the speech signal in children with hearing loss that often cannot benefit from acoustic hearing aids. However, despite the numerous positive results in pediatric cochlear implantation, published data still indicated a wide range of performance among implant recipients. Hence, a need to study the possible variables that can affect performance, could account fo...